柯萨奇B组病毒致病性的分子生物学研究

柯萨奇B组病毒（coxsackievirus group B,CVB）是微小RNA病毒科肠道病毒属成员,病毒性心肌炎的病例中大约有20％-25％是由柯萨奇B组病毒引起。CVB的致病机制十分复杂,病毒基因组以及病毒蛋白均在病毒致病过程中发挥重要作用。因此,对柯萨奇B组病毒的基因组、结构蛋白以及某些非结构蛋白与靶细胞内分子间相互作用生物信息的认识是阐述该病分子机制的基础。     

SiRNA抑制柯萨奇B3病毒的复制和表达

目的 研究观察体外合成siRNA对培养HELA细胞中柯萨奇B3病毒（Coxsackievirus B3,CVB3）的影响。方法根据siRNA靶序列设计原则,针对编码CVB3病毒聚合酶、VP1蛋白和5’非编码区基因组,特异性地体外合成三对siRNA,同时合成一对与CVB基因组序列无关的阴性对照siRNA。利用脂质体转染进入Hela细胞,用CVB3感染培养HELA细胞,观察转染后HELA细胞病变;采用RT-PCR技术检测感染CVB3各组的病毒RNA;用免疫荧光技术检测各组CVB3蛋白的表达;并用培养细胞上清液再感染HELA细胞观察病毒滴度。结果针对CVB3病毒聚合酶的siR-NA能有效的抑制病毒的复制和CVB3蛋白的表达,并能抑制病毒的再感染;而针对VP1蛋白和5’非编码区的siRNA能部分抑制病毒的复制和CVB3蛋白的表达。结论我们设计合成针对编码CVB3病毒聚合酶基因组的siRNA能有效抑制CVB3病毒复制和表达。     

柯萨奇病毒B3型感染引起HeLa细胞内源性小干扰RNA的变化

探究柯萨奇病毒B3型(Coxsackie virus type B3, CVB3)感染的细胞是否诱导内源性小干扰RNA(small interfering RNA,siRNA)的产生。以CVB3接种HeLa细胞,在细胞培养箱(5% CO2、37 ℃)孵育1 h。随后加入含2%血清的细胞维持液,继续培养3 h和6 h后收集细胞。用高通量测序(二代测序) 试剂盒提取细胞RNA,并反转录合成cDNA,构建文库,上机测序。过滤数据,去除插入片段过长的序列、低质量序列、poly A序列和小片段序列,与已知的小RNA数据库比对鉴定siRNA。通过茎-环反转录-聚合酶链反应,证实内源性siRNA在感染CVB3后的表达。结果显示,感染CVB3 3 h和6 h后,HeLa细胞产生了多种内源性siRNA。其中内源性siRNA(novel_sir3502和novel_sir2806)在感染后3 h和6 h均可持续表达。经比对,novel_sir3502和 novel_sir2806均可以识别45S和28S核糖体前体RNA。结果提示,CVB3感染可能干扰核糖体成熟。     

针对2B区域的短双链RNA抑制柯萨奇B3病毒感染HeLa细胞的特性研究

为了研究短双链RNA(Small interfering RNA,siRNA)对柯萨奇B组3型病毒(CVB3)复制的影响及其作用特性,合成针对CVB3基因组2B区的siRNA-2B,脂质体法转染HeLa细胞后感染CVB3病毒,观测转染效率及存留时间、毒性作用、病毒致细胞病变效应、病毒滴度、病毒RNA含量、siRNA-2B对重组基因的特异性降解及培养上清有限稀释后再感染情况.结果发现siRNA-2B能高效转染入HeLa细胞并存留长达48h,高剂量的siRNA-2B对培养细胞无明显毒性,siRNA-2B能特异性针对2B区有效地降解病毒RNA,能明显抑制病毒RNA的复制.随着转染浓度的增加,siRNA-2B的抗病毒作用逐渐增强.siRNA-2B还能明显降低CVB3的再感染能力.这些结果提示,针对基因组2B区的siRNA-2B可以明显抑制CVB3基因复制,有效控制病毒再感染,并具有高效性、特异性和量效关系等特点.为siRNA可能成为预防和治疗CVB3感染的新途径奠定基础.     

柯萨奇病毒B3 cDNA生物素探针的制备研究

本文将柯萨奇B组3型病毒(CVB3)cDNA的重组质粒DNA(pGP51B)转化到E.coli HB101菌株中.筛选转化阳性菌株,经培养扩增后,提取重组质粒DNA,用缺口求移法制备生物素标记探针,通过原位杂交技术检测CVB1.CVB3感染的Hela细胞及正常Hela细胞对照.结果该探针只与CVB杂交,而不与细胞对照杂交,且可检测出病毒感染5h尚未出现病变细胞中的病毒核酸.表明该探针具有良好的特异性和敏感性.     

中国柯萨奇病毒B5的全基因组测序及其序列分析

本文对我国首株与手足口病相关的柯萨奇病毒B5(01/CVB5/SD/CHN/09,CVB5/09)进行了基因组测序并与现有的相关序列进行了比较和进化分析。CVB5/09基因组长7399nt,共编码氨基酸2185aa,与现有的CVB5基因组核酸序列相似性在80.6%～85.3%之间,氨基酸序列相似性在96.1%～96.9%。进化分析发现,利用不同的基因组片段P1、P2和P3区构建的进化树中,CVB5/09分别处在不同的进化分支上,不同基因组片段有着不同的进化速率。Simplot相似性分析没有发现基因组有明显的重组发生。本文完成了我国第1株柯萨奇病毒B5全基因组序列的测定,通过与其它相关病毒的比较分析深入了解其遗传特征,以期为手足口病的流行病学调查和预防控制提供有价值的信息。     

表达红荧光蛋白的重组柯萨奇病毒B组3型基因组稳定性分析

本文旨在分析含红荧光蛋白mCherry基因的重组柯萨奇病毒B组3型（coxsackievirus B3,CVB3）基因组的稳定性。用重组质粒pCVB3-mCherry转染HeLa细胞,观察细胞病变和mCherry的表达。收获病毒后,用噬斑实验纯化病毒并测定病毒毒力。将重组病毒CVB3-mCherry在HeLa细胞中连续传代,提取第2~6代重组病毒总RNA,经反转录-聚合酶链反应（RT-PCR）扩增出报告基因mCherry及CVB3部分序列,进行测序分析。结果表明, CVB3-mCherry转染的HeLa细胞出现细胞病变并表达红荧光蛋白mCherry;从第2代开始, CVB3-mCherry出现报告基因mCherry及部分CVB VP4基因序列丢失,基因序列丢失导致病毒开放读码框架移位。本研究表明,mCherry基因序列的插入导致CVB3基因组不稳定,随着病毒的传代逐渐丢失插入的报告基因mCherry及CVB3基因组的部分序列,病毒读码框移位,产生致死性突变株。因此,应用CVB3-mCherry时,病毒的传代次数应不超过2代,否则应重新从重组质粒中收获病毒,并对每代重组病毒进行纯化和毒力测定。     

简化cDNA末端快速扩增技术测定基因III、VIb和VIId型新城疫病毒基因组末端序列及分析

摘要: 【目的】简化cDNA末端快速扩增技术（Rapid amplification of cDNA ends, RACE）流程,测定基因III、VIb和VIId型新城疫病毒（Newcastle disease virus, NDV）基因组两侧末端序列,并对NDV的leader和trailer进行分析。【方法】利用T4 RNA连接酶将特定寡聚核苷酸片段的连接于病毒基因组RNA和cDNA,再利用RT-PCR或PCR方法对病毒基因组的末端进行快速的扩增。【结果】建立一套操作简单、低成本、可重复性高的RACE方法,测定了三种基因型5株NDV 3’末端leader和5’末端trailer序列比对分析。【结论】本实验测定的鹅源VII型毒株JS/7/05/Ch基因组的15,184 nt由一个T变为了C,5’端trailer与3’端leader的连续互补序列由8 nt变为12 nt,而其它4株基因III型和VI型NDV均未发现该突变。通过RNA的二级结构分析,NDV基因组和反向基因组RNA的3’末端形成一个发卡结构。JS/7/05/Ch等3株NDV U→C（T→C）的突变位于发卡环上,不影响二级结构的形成,发卡环的RNA序列突变为3’-UCUC-5’,与基因组3’端发卡环的3’-UCUUA-5’相似,推测可能影响了基因组RNA的复制速度。     

RNA干扰在柯萨奇病毒致心肌炎小鼠模型中的抗病毒研究

为了研究慢病毒介导的shRNA(Short hairpin RNA,shRNA)在柯萨奇B组3型病毒(Coxsackievirus B3,CVB3)导致的心肌炎小鼠模型中的抗病毒作用,合成针对CVB3基因组3753～3771区域的慢病毒Lenti-sh3753,感染HeLa细胞后感染CVB3病毒,通过荧光显微镜观测shRNA的表达和病毒致细胞病变效应,并测定培养上清中的病毒滴度,将慢病毒Lenti-sh3753感染BALB/c小鼠后感染CVB3病毒,观察小鼠的存活率,心脏组织中的病毒滴度和病理变化。结果发现Lenti-sh3753能在HeLa细胞中表达shRNA,并能有效抑制细胞中病毒RNA的复制。在小鼠模型上,Lenti-sh3753能提高小鼠的存活率,降低心脏中的病毒含量,从而减轻病理反应。这些结果提示,Lenti-sh3753在细胞和动物模型中能针对性地降解CVB3病毒RNA,明显降低病毒滴度,有效控制病毒感染。     

简化cDNA末端快速扩增技术测定基因Ⅲ、Ⅵb和Ⅶ d型新城疫病毒基因组末端序列及分析

[目的]简化cDNA末端快速扩增技术(Rapid amplification of cDNA ends,fLAcE)流程,测定基因Ⅲ、VIb)和VIId型新城疫病毒(Newcastle disease virus,NDV)基因组两侧末端序列,并对NDV的leader和trailer进行分析.[方法]利用T4 RNA连接酶将特定寡聚核苷酸片段的连接于病毒基因组RNA和eDNA,再利用RT-PCR或PCR方法对病毒基因组的末端进行快速的扩增.[结果]建立一套操作简单、低成本、可重复性高的RACE方法,测定了三种基因型5株NDV 3'末端leader和5'末端trailer序列比对分析.[结论]本实验测定的鹅源VII型毒株JS/7/05/Ch基因组的15,184 nt由一个T变为了C,5'端trailer与3'端leader的连续互补序列由8 nt变为12 nt,而其它4株基因Ⅲ型和VI型NDV均未发现该突变.通过RNA的二级结构分析,NDV基因组和反向基因组RNA的3'末端形成一个发卡结构.JS/7/05/Ch等3株NDV U→C(T→C)的突变位于发卡环上,不影响二级结构的形成,发卡环的RNA序列突变为3'-UCUC-5',与基因组3'端发卡环的3'-UCUUA-5'相似,推测可能影响了基因组RNA的复制速度.     

Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion

All ten double-stranded RNA fragments isolated from purified reovirus contain ppGp at the 5′ termini. The presence of a unique 5′-terminal nucleotide indicates that the viral genome in situ consists of segments which are synthesized as discrete units in infected cells. The penultimate base is a pyrimidine. This 5′ sequence, ppGpPyp, is identical to that reported previously for the ten reovirus messenger RNA species synthesized in vitro. The results indicate that the double-stranded RNA segments are perfect duplexes which are transcribed end-to-end by the virion-associated RNA polymerase.     

Comparative restriction endonuclease maps of proviral DNA of the primate type C simian sarcoma-associated virus and gibbon ape leukemia virus group.

Extrachromosomal DNA was purified from canine thymus cells acutely infected with different strains of infectious primate type C viruses of the woolly monkey (simian) sarcoma helper virus and gibbon ape leukemia virus group. All DNA preparations contained linear proviral molecules of 9.1 to 9.2 kilobases, at least some of which represent complete infectious proviral DNA. Cells infected with a replication-defective fibroblast-transforming sarcoma virus and its helper, a replication-competent nontransforming helper virus, also contained a 6.6- to 6.7-kilobase DNA. These proviral DNA molecules were digested with different restriction endonucleases, and the resultant fragments were oriented to the viral RNA by a combination of partial digestions, codigestion with more than one endonuclease, digestion of integrated proviral DNA, and hybridization with 3'- and 5'-specific viral probes. The 3'- and 5'-specific probes each hybridized to fragments from both ends of proviral DNA, indicating that, in common with those of other retroviruses, these proviruses contain a large terminal redundancy at both ends, each of which consists of sequences derived from both the 3' and 5' regions of the viral RNA. The proviral sequences are organized 3',5'-unique-3',5'. Four restriction enzymes (KpnI, SmaI, PstI, and SstI) recognized sites within the large terminal redundancies, and these sites were conserved within all the isolates tested. This suggests that both the 3' and 5' ends of the genomic RNA of these viruses are extremely closely related. In contrast, the restriction sites within the unique portion of the provirus were not strongly conserved within this group of viruses, even though they were related along most of their genomes. Whereas the 5' 60 to 70% of the RNA of these viruses was more closely related by liquid hybridization experiments than was the 3' 30 to 40%, restriction sites within this region were not preferentially conserved, suggesting that small sequence differences or point mutations or both exist throughout the entire unique portion of the genome among these viruses.     

5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA

Adult human enteroviral heart disease is often associated with the detection of enteroviral RNA in cardiac muscle tissue in the absence of infectious virus. Passage of coxsackievirus B3 (CVB3) in adult murine cardiomyocytes produced CVB3 that was noncytolytic in HeLa cells. Detectable but noncytopathic CVB3 was also isolated from hearts of mice inoculated with CVB3. Sequence analysis revealed five classes of CVB3 genomes with 5' termini containing 7, 12, 17, 30, and 49 nucleotide deletions. Structural changes (assayed by chemical modification) in cloned, terminally deleted 5'-nontranslated regions were confined to the cloverleaf domain and localized within the region of the deletion, leaving key functional elements of the RNA intact. Transfection of CVB3 cDNA clones with the 5'-terminal deletions into HeLa cells generated noncytolytic virus (CVB3/TD) which was neutralized by anti-CVB3 serum. Encapsidated negative-strand viral RNA was detected using CsCl-purified CVB3/TD virions, although no negative-strand virion RNA was detected in similarly treated parental CVB3 virions. The viral protein VPg was detected on CVB3/TD virion RNA molecules which terminate in 5' CG or 5' AG. Detection of viral RNA in mouse hearts from 1 week to over 5 months postinoculation with CVB3/TD demonstrated that CVB3/TD virus strains replicate and persist in vivo. These studies describe a naturally occurring genomic alteration to an enteroviral genome associated with long-term viral persistence.     

Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis.

In vitro replication of coxsackievirus B3 (CVB3) in cells of the immune system derived from uninfected adolescent A/J and C57BL/6J mice and replication of CVB3 in and association with immune cells from spleens of infected animals in vivo were assessed. Nonstimulated or mitogen-stimulated spleen cells were minimally permissive for viral replication during an 8-h period. Three days postinfection (p.i.), CVB3 RNA was localized in vivo to B cells and follicular dendritic cells of germinal centers in both A/J and C57BL/6J mice; however, extrafollicular localization was greater in C57BL/6J mice (P = 0.0054). Although the pattern of CVB3 RNA localization was different, the total load of infections virus (PFU per milligram of tissue) was not different. Splenic CVB3 titers (PFU per milligram of tissue) in both strains were maximal at day 3 or 4 p.i. and were back to baseline by day 7 p.i., with most infectious virus being non-cell associated. CVB3 titers (PFU per milligram of tissue) correlated directly with in situ hybridization positivity in splenic follicles and extrafollicular regions in both murine strains; however, follicular hybridization intensity was greater in A/J mice at day 5 p.i. (P = 0.021). Flow cytometric analysis demonstrated that 50.4% of total spleen cells positive for CVB3 antigen were B cells and 69.6% of positive splenic lymphocytes were B cells. Myocardial virus load in C57BL/6J mice was significantly lower than that in A/J mice at days 4 and 5 p.i. These data indicate that CVB3 replicates in murine splenocytes in vitro and in B cells and extrafollicular cells in vivo.     

Discontinuous synthesis of both strands at the growing fork during polyoma DNA replication in vitro.

In discontinuous polyoma DNA replication, the synthesis of Okazaki fragments is primed by RNA. During viral DNA synthesis in nuclei isolated from infected cells, 40% of the nascent short DNA fragments had the polarity of the leading strand which, in theory, could have been synthesized by a continuous mechanism. To rule out that the leading strand fragments were generated by degradation of nascent DNA, they were further characterized. DNA fragments from a segment of the genome which replication forks pass in only one direction were strand separated. The sizes of the fragments from both strands were similar, suggesting that one strand was not specifically degraded. Most important, however, the majority of the Okazaki fragments of both strands were linked to RNA at their 5' ends. For identification, the RNA was labeled at the 5' ends by [beta-32P]GTP, internally by [3H]CTP, [3H]GTP, and [3H]UTP, or at the 3' ends by 32P transfer from adjacent [32P]dTMP residues. All three kinds of labeling indicated that an equal proportion of DNA fragments from the two strands was linked to RNA primers.     

Defective interfering viral particles in acute dengue infections

While much of the genetic variation in RNA viruses arises because of the error-prone nature of their RNA-dependent RNA polymerases, much larger changes may occur as a result of recombination. An extreme example of genetic change is found in defective interfering (DI) viral particles, where large sections of the genome of a parental virus have been deleted and the residual sub-genome fragment is replicated by complementation by co-infecting functional viruses. While most reports of DI particles have referred to studies in vitro, there is some evidence for the presence of DI particles in chronic viral infections in vivo. In this study, short fragments of dengue virus (DENV) RNA containing only key regulatory elements at the 3' and 5' ends of the genome were recovered from the sera of patients infected with any of the four DENV serotypes. Identical RNA fragments were detected in the supernatant from cultures of Aedes mosquito cells that were infected by the addition of sera from dengue patients, suggesting that the sub-genomic RNA might be transmitted between human and mosquito hosts in defective interfering (DI) viral particles. In vitro transcribed sub-genomic RNA corresponding to that detected in vivo could be packaged in virus like particles in the presence of wild type virus and transmitted for at least three passages in cell culture. DENV preparations enriched for these putative DI particles reduced the yield of wild type dengue virus following co-infections of C6-36 cells. This is the first report of DI particles in an acute arboviral infection in nature. The internal genomic deletions described here are the most extensive defects observed in DENV and may be part of a much broader disease attenuating process that is mediated by defective viruses.     

Formation of extrachromosomal circular DNA in HeLa cells by nonhomologous recombination.

Extrachromosomal circular DNA (eccDNA) generated from chromosomal DNA is found in all mammalian cells and increases with cell stress or aging. Studies of eccDNA structure and mode of formation provide insight into mechanisms of instability of the mammalian genome. Previous studies have suggested that eccDNA is generated through a process involving recombination between repetitive sequences. However, we observed that approximately one half of the small eccDNA fragments cloned from HeLa S3 cells were composed entirely of nonrepetitive or low-copy DNA sequences. We analyzed four of these fragments by polymerase chain reaction and nucleotide sequencing and found that they were complete eccDNAs. We then screened a human genomic library with the eccDNAs to isolate the complementary chromosomal sequences. Comparing the recombination junctions within the eccDNAs with the chromosomal sequences from which they were derived revealed that nonhomologous recombination was involved in their formation. One of the eccDNAs was composed of two separate sequences from different parts of the genome. These results suggest that rejoining of ends of fragmented DNA is responsible for the generation of a substantial portion of the eccDNAs found in HeLa S3 cells.     

柯萨奇B3病毒基因在重组痘苗病毒中的表达

将编码柯萨奇Ｂ３病毒（ＣＶＢ３）衣壳蛋白ＶＰ１和ＶＰ２的基因,分别克隆到具有７．５ｋ启动子的痘苗病毒表达载体ｐＧＪＰ５上;将ＣＶＢ３衣壳蛋白全基因克隆到具有Ｔ７启动子的痘苗表达载体ｐＴＭ１上,并筛先到相应的重组痘苗病毒ＶＶＰ１、ＶＶＰ２和ＶＶＰ／４／２／３／１。ＶＶＰ１和ＶＶＰ２稳定表达产物为ＣＶＢ３衣壳蛋白ＶＰ１和ＶＰ２,而ＶＶＰ４／２／３／１为一无分泌性的多聚蛋白,且这三种表达产物均属无分泌性     

The substitution U<Subscript>475</Subscript> → C with Sabin3-like mutation within the IRES attenuate Coxsackievirus B<Subscript>3</Subscript> cardiovirulence

The Sabin3 mutation in the viral RNA plays an important role in directing attenuation phenotype of Sabin vaccine strain of poliovirus type 1 (PV1). We previously described that Sabin3-like mutation introduced in Coxsackievirus B3 (CVB3) genome led to a defective mutant. However, this mutation do not led to destruction of secondary structure motif C within the stem-loop V of CVB3 RNA because of the presence of one nucleotide difference (C → U) in the region encompassing the Sabin3 mutation at nucleotides 471 of PV1 and 475 of CVB3 RNA. In order to reproduce the same sequence of PV1 sabin3 vaccine strain, we introduce in this study an additional mutation (U₄₇₅ → C) to CVB3 Sabin3-like mutant. Our results demonstrated that Sabin3-like+C mutant displayed a decreased translation initiation defects when translated in cell-free system. This translation initiation defect was correlated with reduced yields of infectious virus particles in HeLa cells in comparison with Sabin3-like mutant and wild-type CVB3 viruses. Inoculation of Swiss mice with mutant viruses resulted in no inflammatory heart disease when compared to heart of mice infected with wild-type. Theses findings indicate that the double mutant could be exploited for the development of a live attenuated vaccine against CVB3.